Key result
In patients with acute decompensated heart failure, 180-day mortality was similar between low (<40%) and preserved (>50%) ejection fraction groups (HR 0.96; 95% CI 0.75-1.24; P=0.77).
Why the study?
Does left ventricular ejection fraction predict 30 and 180 day mortality in patients with acute decompensated heart failure?
Population
7,007 patients with acute decompensated heart failure (ADHF) enrolled in the ASCEND-HF trial
Comparison
Left ventricular ejection fraction < 40% or 40-50% vs LVEF > 50% (PresEF)
Design
Cohort
Follow-up
180 days
Authors
Loading...
Similar mortality across LVEF groups warrants caution in prognostication; leaves open adjusted risks below 35%.
Observational (n=7,007)
Does left ventricular ejection fraction predict 30 and 180 day mortality in patients with acute decompensated heart failure?
Effect estimate: HR 0.96 (95% CI 0.75-1.24)
Absolute Event Rate: 12.3% vs 14.1%
p-value: p=0.77
In patients with acute decompensated heart failure, unadjusted mortality rates are similar across LVEF strata, but after adjusting for key variables, mortality risk increases as LVEF falls below 35%.
Toma et al. (2013) conducted an observational in Acute decompensated heart failure (ADHF) (n=7,007). Low ejection fraction (<40%) vs. Preserved ejection fraction (>50%) was evaluated on 180-day mortality (HR 0.96, 95% CI 0.75-1.24, p=0.77). In patients with acute decompensated heart failure, 180-day mortality was similar between low (<40%) and preserved (>50%) ejection fraction groups (HR 0.96; 95% CI 0.75-1.24; P=0.77).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: